Flinn, I. W., Ruppert, A. S., Harwin, W., Waterhouse, D., Papish, S., Jones, J. A., . . . Byrd, J. C. (2016). A Phase II Study of Two Dose Levels of Ofatumumab Induction followed by Maintenance Therapy in Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia (CLL). Am J Hematol.
Citación estilo ChicagoFlinn, Ian W., Amy S. Ruppert, William Harwin, David Waterhouse, Steven Papish, Jeffrey A. Jones, John Hainsworth, y John C. Byrd. "A Phase II Study of Two Dose Levels of Ofatumumab Induction Followed By Maintenance Therapy in Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia (CLL)." Am J Hematol 2016.
Cita MLAFlinn, Ian W., et al. "A Phase II Study of Two Dose Levels of Ofatumumab Induction Followed By Maintenance Therapy in Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia (CLL)." Am J Hematol 2016.